Chairman/Ceo, Cofounder/Chief Scientist, Nasa-Trained Commercial Astronaut
Current
Tokyo, Japan, Jp
Christopher Altman is an American physicist, quantum technologist, international diplomat and NASA-trained commercial astronaut who began his scientific career with a world record-holding artificial intelligence project and NASA/USAF–supported time travel division at multidisciplinary, “Deep Future” research institute Starlab, featured in a Discovery Channel Special and the Guinness Book of World Records. As Director of the Board and Chief Science Officer for the world's first commercial astronaut corps, then as a Director with the successor to NASA’s Breakthrough Propulsion Physics program, his research spans the fields of quantum technology and next-generation spaceflight (TU Delft, NASA, Harvard). His inaugural keynote address as astronaut candidate was broadcast live to 108 cities around the world: NASA allocated funding to the corps for its first manned spaceflights the following spring. Altman conveys a wealth of experience briefing US national IC and research agency directors, global travels to draft long-term national quantum roadmaps; foundational research in quantum physics with Nobel laureate Anton Zeilinger Austrian research group; leading diverse, multidisciplinary teams of scientists, researchers, engineers, and special forces domain experts in austere environs, field testing state-of-the-art sensors — all under the same unifying objective: to make a profound and positive impact on the next generation and the generations yet to come. Contemporary foci: USSOCOM, USAF, US Space Force, macroscopic coherent absorbers, Wheeler-Feynman advanced wave time symmetrical QM, caudate putamen, BCI, superconducting quantum interference device, ER=EPR, quantum entanglement. Einstein-Rosen bridge, relativistic quantum effects. UAP/USO/NHI/biologics, exotic materials, rapid response tiger team, crash recovery, reverse engineering, deep space, breakthrough propulsion, next-generation manned spaceflight. QuIST/quantum AI, AGI/ASI alignment, apotheosis.